Recently, the Asia Medical Aesthetics Summit & the 2nd Injectable Medical Aesthetics Summit was grandly
held in Chengdu, China, attracting medical aesthetics experts and industry elites from across Asia.
Dr. Zhang Jie of Xinmixue was invited to deliver a keynote speech, providing a systematic science
popularization on the principles and application prospects of stem cells and exosomes, and showcasing
the company’s latest technological achievements on site.
Conference Highlights
The summit served as a premier platform for academic exchange in the medical aesthetics field, bringing
together authoritative experts, industry leaders, and technology innovators from multiple countries and regions.
Through keynote speeches, panel discussions, and technical showcases, participants explored the latest
trends and clinical advancements in injectable medical aesthetics.
Dr. Zhang Jie’s Presentation
As one of the distinguished guest speakers, Dr. Zhang Jie from Xinmixue delivered a keynote speech titled
“Frontiers in Stem Cell and Exosome Science”. The presentation began with an introduction to the fundamentals
of stem cell biology, followed by an in-depth explanation of the structure, composition, and intercellular communication
mechanisms of exosomes. Dr. Zhang also discussed the potential applications of these cutting-edge biotechnologies
in personalized medical aesthetics solutions, while emphasizing the importance of scientific rigor and safety standards.
Xinmixue’s Industry Contribution
Xinmixue has long been committed to research and innovation in stem cell and exosome technologies, focusing on
translating laboratory breakthroughs into practical applications. The company has established a comprehensive R&D
system, maintains collaborations with leading laboratories, and continuously invests in technological upgrades. At the
summit, Xinmixue showcased its proprietary process optimization techniques, highlighting its capability to deliver
high-quality, standardized biological products.
Future Outlook
Moving forward, Xinmixue will continue to deepen its expertise in regenerative medical aesthetics, strengthen
collaborations with global research institutions, and actively promote the healthy and sustainable development of
the industry.